Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis
about
Computerised cognition-based interventions for preventing dementia in people with mild cognitive impairmentThe diagnosis and management of mild cognitive impairment: a clinical review.Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of AgingPrediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort.Cognitively elite, cognitively normal, and cognitively impaired aging: neurocognitive status and stability moderate memory performance.Art therapy and music reminiscence activity in the prevention of cognitive decline: study protocol for a randomized controlled trialThe spectrum of cognitive impairment in Lewy body diseasesAPOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.Mild cognitive impairment and mild dementia: a clinical perspective.Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errorsMotoric cognitive risk syndrome: Multicenter incidence study.Driving and dementia: a clinical decision pathway.Anterior cingulate cortex mediates the relationship between O3PUFAs and executive functions in APOE e4 carriersCumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach.Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's DiseaseFactors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based studyEfficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions.Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease.Classification and epidemiology of MCI.Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.Risk factors for the progression of mild cognitive impairment to dementia.Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic.Alzheimer's disease CSF biomarkers: clinical indications and rational use.Predictors That a Diagnosis of Mild Cognitive Impairment Will Remain Stable 3 Years Later.Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition.Precuneus Structure Changes in Amnestic Mild Cognitive Impairment.Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care.Utilization of healthcare services among elderly with cognitive impairment no dementia and influence of depression and anxiety: a longitudinal study.A case of misdiagnosis of mild cognitive impairment: The utility of symptom validity testing in an outpatient memory clinic.Mente Activa® Improves Impaired Spatial Memory in Aging Rats.Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study.Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care Population.Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.Mild cognitive impairment (MCI) in long-term care patients: subtype classification and occurrence.Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention.
P2860
Q26471295-D08D231A-149C-481D-B775-4E8011E92E27Q27693353-B0B14E01-B2D6-418D-A888-A44353AE8E08Q28083708-8EDD8564-93A3-4D1F-A3FE-EFDCD9FB579EQ30996721-FD9C7679-F2EE-4228-9C0E-953263A97C79Q31036429-D2934EFB-BAB4-4AEA-AFCC-8E0A4BEDBFC0Q33782301-162699EF-B3A5-4F6D-B496-D9B56C7E52A3Q33901154-19232DAB-449C-4328-8580-2836A399DBDFQ34019751-AAE3BE46-B060-4605-9E10-DABE01223392Q34139700-2BC032FD-FCE0-4D1A-BF92-AEAA81379D7EQ34231888-DB800F41-9973-4424-8EDE-AB61DE58A7B1Q34289991-812A7D9B-942A-45B7-AA09-2348CF7DDFEEQ34560120-2CA19694-7EDD-4879-A41D-70A1B8D86538Q34777901-E2361725-E8EC-471D-8307-CD5807419FC8Q35008622-F1B0CBAE-B060-45A7-9FEE-9792DFF98C29Q35630790-0E55115A-161F-46F1-B948-55DE35760933Q35687278-A6D58A87-7837-490D-8B69-0C2F2E75E9C1Q36252707-9AAB14F3-F21A-408B-BCB2-C5702A5BCA38Q36721497-2E990AE4-A55C-455E-A759-DF27EB3A0525Q36807552-C58F51C1-DA15-43AC-8C6D-2C0DBB77B7A3Q37126328-C6514073-D24F-4376-9AC7-391EE51478D3Q37290686-72FC2C37-B989-4E52-9A0C-0EB3DDE1A26FQ37407631-83554785-B79E-4F40-85D4-8346EE77DA63Q37593256-11CA7AEB-B594-411C-99D6-84FCB76DD2ABQ38149355-22B9B68C-0D61-4B9B-8E4A-491AF324AB5EQ38377766-643D4A35-27A7-44CD-B4D0-AA11A55AC128Q38601553-E6EEB0E5-1657-4A23-8B71-70B70CED3E86Q38650548-44E7D61B-F82F-4F08-AFA5-632A321D27F5Q38890463-46FAB75F-EF4F-46D0-A016-6E6661E4F8ACQ38890671-D2094930-D8A0-4D1D-BA22-5EDA57DE5FE1Q38903030-BC0A5411-8419-491A-A075-9F20C22B46E1Q39014178-7F146002-0450-4BD2-ADD8-E0B07DC0F016Q39164383-5752391D-A7F1-433C-91CB-974725E9CC74Q39902481-48F34BA5-1265-432D-A648-0D29B1CAFAB9Q40398440-59866E62-017F-4044-890E-8E4AEB656453Q40494042-1C26C8DD-A0A7-476C-9FD7-CADF31E53253Q40547409-9F241B00-0921-451C-AD48-013C7C934C9BQ40881023-8B99CCC3-2E44-4E9C-A9A8-C82296440CBCQ40935892-E13E5EA3-ED8B-43BC-8E40-1A4191CA167DQ41509584-85B3DDE6-9515-4D50-9125-6B7B8F911E66Q42846139-9D7D54E2-F591-4F59-83CD-34955EB46102
P2860
Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Reversion from mild cognitive ...... on: risk factors and prognosis
@ast
Reversion from mild cognitive ...... on: risk factors and prognosis
@en
type
label
Reversion from mild cognitive ...... on: risk factors and prognosis
@ast
Reversion from mild cognitive ...... on: risk factors and prognosis
@en
prefLabel
Reversion from mild cognitive ...... on: risk factors and prognosis
@ast
Reversion from mild cognitive ...... on: risk factors and prognosis
@en
P2860
P1433
P1476
Reversion from mild cognitive ...... on: risk factors and prognosis
@en
P2093
Sarah E Monsell
Thomas D Koepsell
P2860
P304
P356
10.1212/WNL.0B013E31826E26B7
P407
P577
2012-09-26T00:00:00Z